Hochman Cole Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Hochman Cole Investment Advisors's PFE Position: Q4 2020 in Review
Hochman Cole Investment Advisors sold out of Pfizer (PFE) in Q4 2020, closing a stake of 10,936 shares — an estimated $381K sold.
Hochman Cole Investment Advisors first reported a position in PFE in Q4 2015 and held it in 20 quarters. The position peaked at $576K in Q3 2018. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.
- Hochman Cole Investment Advisors reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
- Hochman Cole Investment Advisors sold 10,936 Pfizer shares in Q4 2020, an estimated $381K.
- Hochman Cole Investment Advisors first reported a position in Pfizer in Q4 2015 and held it in 20 quarters.
- Hochman Cole Investment Advisors's Pfizer position peaked at $576K in Q3 2018.
- 2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.
Based on Hochman Cole Investment Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.